Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia

被引：23

作者：

Metlay, JP ^{[1
]}

机构：

[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2004年 / 18卷 / 04期

关键词：

D O I：

10.1016/j.idc.2004.07.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This article challenges the assertion that current levels of antibacterial drug resistance should influence treatment decisions for patients who have community-acquired pneumonia (CAP). The article will discuss the following topics related to patients who have CAP: (1) the relevant bacteriologic and clinical outcomes that should be investigated to inform empirical treatment, (2) the study design options for studying the impact of antibacterial drug resistance on bacteriologic and clinical outcomes, and (3) the evidence that antibacterial drug resistance influences bacteriologic and clinical outcomes.

引用

页码：777 / +

页数：16

共 65 条

[1] Pneumococcal macrolide resistance - myth or reality? [J].

Amsden, GW .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) :1-6

[2]

[Anonymous], 2001, CROSSING QUALITY CHA

[3] Drug-resistant pneumococcal pneumonia:: Clinical relevance and related factors [J].

Aspa, J ;

Rajas, O ;

de Castro, FR ;

Blanquer, J ;

Zalacain, R ;

Fenoll, A ;

de Celis, R ;

Vargas, A ;

Salvanés, FR ;

España, PP ;

Rello, J ;

Torres, A .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) :787-798

[4] PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA [J].

AUSTRIAN, R ;

GOLD, J .

ANNALS OF INTERNAL MEDICINE, 1964, 60 (05) :759-+

[5]

Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954

[6]

Blondeau J M, 2000, Semin Respir Infect, V15, P195

[7] Streptococcus pneumoniae:: Bacteremia in an era of penicillin resistance [J].

Castillo, EM ;

Rickman, LS ;

Brodine, SK ;

Ledbetter, EK ;

Kelly, C .

AMERICAN JOURNAL OF INFECTION CONTROL, 2000, 28 (03) :239-243

[8] Antimicrobial resistance in Streptococcus pneumoniae:: Implications for patients with community-acquired pneumonia [J].

Chenoweth, CE ;

Saint, S ;

Martinez, F ;

Lynch, JP ;

Fendrick, AM .

MAYO CLINIC PROCEEDINGS, 2000, 75 (11) :1161-1168

[9] Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy [J].

Dagan, R ;

Klugman, KP ;

Craig, WA ;

Baquero, F .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (02) :129-140

[10] Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. [J].

Davidson, R ;

Cavalcanti, R ;

Brunton, JL ;

Bast, DJ ;

de Azavedo, JCS ;

Kibsey, P ;

Fleming, C ;

Low, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) :747-750

← 1 2 3 4 5 6 7 →